Drug:
Reaction: DRUG INEFFECTIVE
20250101 - 20251231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 25140950 |
US |
||
Drug ineffective, |
||||
IBUPROFEN, IBUPROFEN AND DIPHENHYDRAMINE CITRATE, |
||||
| 102 | 25140961 |
US |
||
Drug ineffective, |
||||
| 103 | 25140977 |
US |
76 | 1 |
Drug ineffective, Large intestine perforation, Cytomegalovirus colitis, Therapy non-responder, |
||||
MESALAMINE, METHYLPREDNISOLONE, INFLIXIMAB, PENTOXIFYLLINE, |
||||
| 104 | 25140992 |
US |
||
Drug ineffective, |
||||
LORATADINE, LORATADINE TABLET, |
||||
| 105 | 25141020 |
US |
||
Drug ineffective, |
||||
NAPROXEN SODIUM, NAPROXEN SODIUM TABLET, |
||||
| 106 | 25141030 |
|||
Drug ineffective, |
||||
OXYBUTYNIN, |
||||
| 107 | 25141034 |
US |
2 | |
Productive cough, Sputum discoloured, Drug ineffective, |
||||
ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, |
||||
| 108 | 25141043 |
|||
Drug ineffective, Therapy change, |
||||
TIRZEPATIDE, |
||||
| 109 | 25141050 |
CA |
47 | 2 |
Cardiac failure congestive, Drug hypersensitivity, Nausea, Malaise, Drug ineffective, Diarrhoea, Abdominal discomfort, Abdominal pain upper, Arthralgia, Cough, Rash, Headache, Off label use, Product use issue, Hepatic enzyme increased, Liver disorder, Pain, Cardiac failure, Hypersensitivity, Dyspnoea, Gastrointestinal disorder, Hepatic steatosis, Hypertension, Therapeutic product effect decreased, Contraindicated product administered, |
||||
RABEPRAZOLE SODIUM, RABEPRAZOLE, RANITIDINE, COLCHICINE, PATIROMER, CELECOXIB, CEPHALEXIN, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, LEFLUNOMIDE, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, ENALAPRIL, ETANERCEPT, ALENDRONATE SODIUM, HYDRALAZINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, LOSARTAN, METHOTREXATE, METHOTREXATE SODIUM, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, MOXIFLOXACIN HYDROCHLORIDE, ABATACEPT, PENICILLIN G, HYDROXYCHLOROQUINE SULFATE, ISONIAZID, TOFACITINIB, RITUXIMAB, ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, ALENDRONATE SODIUM, CLARITHROMYCIN, HYDROXYCHLOROQUINE SULFATE, LEFLUNOMIDE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, IRON SUCROSE, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, PERINDOPRIL ERBUMINE, PREDNISONE, ATENOLOL, LEVOTHYROXINE, |
||||
| 110 | 25141152 |
AU |
2 | |
Nephrolithiasis, Urinary tract infection, Brain fog, Dizziness, Drug ineffective, |
||||
GALCANEZUMAB-GNLM, ERENUMAB-AOOE, TOPIRAMATE, TOPIRAMATE SPINKLE, FREMANEZUMAB-VFRM, ONABOTULINUMTOXINA, PROPRANOLOL HYDROCHLORIDE, |
||||
| 111 | 25141268 |
US |
43 | 2 |
Neoplasm progression, Drug ineffective for unapproved indication, Drug ineffective, |
||||
ETOPOSIDE, ETOPOSIDE, DOXORUBICIN, DOXORUBICIN, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, CISPLATIN, CISPLATIN, MITOTANE, MITOTANE, METYRAPONE, PEMBROLIZUMAB, PEMBROLIZUMAB, |
||||
| 112 | 25141329 |
US |
||
Drug ineffective, |
||||
INCOBOTULINUMTOXINA, INCOBOTULINUMTOXINA, INCOBOTULINUMTOXINA, |
||||
| 113 | 25141365 |
US |
||
Bladder cancer recurrent, Drug ineffective, |
||||
NADOFARAGENE FIRADENOVEC-VNCG, |
||||
| 114 | 25141389 |
CA |
88 | 2 |
Fall, Drug ineffective, Abdominal pain lower, Frequent bowel movements, Constipation, Fatigue, Pain, Sensitivity to weather change, COVID-19, |
||||
TOFACITINIB, TOFACITINIB, TOFACITINIB, CELECOXIB, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, DENOSUMAB, RITUXIMAB, LEVOTHYROXINE SODIUM, |
||||
| 115 | 25141415 |
US |
4 | 2 |
Rash erythematous, Pruritus, Skin burning sensation, Condition aggravated, Dermatitis atopic, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 116 | 25141505 |
US |
68 | 1 |
Drug ineffective, |
||||
DUPILUMAB, FINASTERIDE, LOSARTAN POTASSIUM, LOSARTAN, OXYBUTYNIN CHLORIDE, TAMSULOSIN HYDROCHLORIDE, |
||||
| 117 | 25141519 |
US |
42 | 1 |
Eczema, Drug ineffective, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 118 | 25141549 |
US |
20 | 1 |
Drug ineffective, |
||||
DUPILUMAB, |
||||
| 119 | 25141598 |
US |
2 | |
Sleep disorder due to a general medical condition, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 120 | 25141634 |
US |
63 | 1 |
Drug ineffective, |
||||
DUPILUMAB, |
||||
| 121 | 25141675 |
US |
2 | |
Blood glucose increased, Drug ineffective, |
||||
INSULIN GLULISINE, INSULIN GLARGINE, |
||||
| 122 | 25141684 |
DE |
74 | 2 |
Drug ineffective, Anti-neuronal antibody, Paraneoplastic neurological syndrome, |
||||
CARBOPLATIN, CARBOPLATIN, ATEZOLIZUMAB, ETOPOSIDE, ETOPOSIDE, |
||||
| 123 | 25141688 |
CN |
65 | 1 |
Dysuria, Urinary retention, Drug ineffective, |
||||
MORPHINE SULFATE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 124 | 25141702 |
|||
Drug ineffective, |
||||
FAMOTIDINE, |
||||
| 125 | 25141714 |
US |
1 | |
Drug ineffective, |
||||
ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, |
||||
| 126 | 25141715 |
CH |
76 | 2 |
Disseminated tuberculosis, Drug ineffective, Bovine tuberculosis, Tuberculosis, |
||||
LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, |
||||
| 127 | 25141737 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 128 | 25141746 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 129 | 25141748 |
US |
2 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 130 | 25141749 |
US |
2 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 131 | 25141769 |
CA |
43 | 2 |
Asthenia, Blood cholesterol increased, Drug ineffective, Exposure during pregnancy, Hypertension, Liver function test increased, Liver injury, Maternal exposure during pregnancy, Memory impairment, Mobility decreased, Muscular weakness, Musculoskeletal stiffness, Nausea, Oedema, Off label use, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Prescribed overdose, Product use in unapproved indication, Product use issue, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Seronegative arthritis, Sleep disorder, Swelling, Spondylitis, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Therapeutic product effect decreased, Treatment failure, Type 2 diabetes mellitus, Vomiting, Weight decreased, Wheezing, Wound, Wound infection, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, APREMILAST, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CALCIUM CARBONATE, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, ADALIMUMAB-ADAZ, INFLIXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, INFLIXIMAB, RITUXIMAB, RITUXIMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, AZATHIOPRINE, ERYTHROMYCIN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LISINOPRIL, LISINOPRIL, MAGNESIUM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, RISEDRONATE SODIUM, SULFASALAZINE, |
||||
| 132 | 25141786 |
US |
2 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 133 | 25141787 |
US |
49 | 2 |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 134 | 25141789 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 135 | 25141794 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 136 | 25141795 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 137 | 25141797 |
US |
||
Drug effect less than expected, Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 138 | 25141801 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 139 | 25141803 |
US |
2 | |
Drug ineffective, |
||||
NALTREXONE, |
||||
| 140 | 25141806 |
US |
88 | 1 |
Drug ineffective, |
||||
POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350, APIXABAN, |
||||
| 141 | 25141815 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 142 | 25141816 |
US |
37 | 1 |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 143 | 25141848 |
US |
42 | 2 |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 144 | 25141849 |
US |
42 | 2 |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 145 | 25141853 |
US |
2 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 146 | 25141855 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 147 | 25141856 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 148 | 25141869 |
US |
2 | |
Drug ineffective, |
||||
INTERFERON BETA-1B, |
||||
| 149 | 25141875 |
US |
||
Drug ineffective, |
||||
NAPROXEN SODIUM, NAPROXEN SODIUM TABLET, |
||||
| 150 | 25141884 |
US |
||
Drug ineffective, Drug effect less than expected, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 151 | 25141886 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 152 | 25141891 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 153 | 25141893 |
US |
2 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 154 | 25141901 |
US |
63 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 155 | 25141916 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 156 | 25141920 |
US |
62 | 2 |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 157 | 25141921 |
US |
60 | 2 |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 158 | 25141922 |
US |
1 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 159 | 25141923 |
US |
1 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 160 | 25141926 |
US |
2 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 161 | 25141928 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 162 | 25141930 |
US |
||
Drug effect less than expected, Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 163 | 25141931 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 164 | 25141957 |
US |
2 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 165 | 25141958 |
US |
2 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 166 | 25141959 |
US |
1 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 167 | 25141960 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 168 | 25141962 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 169 | 25141963 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 170 | 25141967 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 171 | 25141972 |
US |
43 | 2 |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 172 | 25141973 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 173 | 25141990 |
US |
20 | 2 |
Toxicity to various agents, Somnolence, Cardiac arrest, Vasoplegia syndrome, Drug ineffective, Pulmonary oedema, Hypotension, Multiple organ dysfunction syndrome, Cardiac failure high output, Generalised oedema, Hypoxia, Overdose, Renal failure, |
||||
EPINEPHRINE, ADRENALINUM, AMLODIPINE, VASOPRESSIN, CALCIUM, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, GLUCAGON, METHYLENE BLUE, |
||||
| 174 | 25141993 |
ES |
38 | 2 |
Enterococcal infection, Meningitis, Drug ineffective, |
||||
ETOPOSIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYTARABINE, CISPLATIN, RITUXIMAB, IFOSFAMIDE, DOXORUBICIN, PREDNISONE, |
||||
| 175 | 25142002 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 176 | 25142003 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 177 | 25142007 |
US |
60 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 178 | 25142008 |
US |
29 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 179 | 25142010 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 180 | 25142011 |
US |
2 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 181 | 25142013 |
US |
2 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 182 | 25142014 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 183 | 25142017 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 184 | 25142033 |
BR |
||
Generalised oedema, Glomerulonephritis, Renal impairment, Systemic lupus erythematosus, Drug ineffective, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, METHYLPREDNISOLONE, |
||||
| 185 | 25142054 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 186 | 25142055 |
US |
2 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 187 | 25142057 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 188 | 25142059 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 189 | 25142064 |
US |
2 | |
Drug ineffective, Product use in unapproved indication, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 190 | 25142068 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 191 | 25142070 |
US |
67 | 2 |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 192 | 25142071 |
US |
60 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 193 | 25142072 |
US |
2 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 194 | 25142076 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 195 | 25142078 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 196 | 25142079 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 197 | 25142080 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 198 | 25142081 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 199 | 25142082 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 200 | 25142083 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28